**Title: United Therapeutics to Announce Q3 2024 Financials on October 30, 2024**
**Key Points for Biotech Investors:**
– **Announcement Date:** United Therapeutics Corporation (Nasdaq: UTHR) will report its Q3 2024 financial results before market open on Wednesday, October 30, 2024.
– **Press Release Time:** A detailed press release will be issued at approximately 6:30 a.m. Eastern Time, offering insights into the company’s performance during the quarter.
– **Webcast Details:** A public webcast is scheduled for the same day, at 9:00 a.m. Eastern Time, allowing investors and stakeholders to gain in-depth information and ask questions about the company’s financial status and future outlook.
Investors can access the webcast and press release for comprehensive details and analysis of United Therapeutics’ Q3 performance and prospects in the evolving pharmaceutical sector. For more information, please visit the official announcement on [Business Wire](http://www.businesswire.com/portal/site/home/news/industry/?vnsId=31070).
Staying attuned to these updates can provide crucial insights into therapeutic advancements and regulatory interactions impacting United Therapeutics, enhancing informed decision-making in the biotech investment sphere.